| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $93.5M | +208.8% |
| Cost of Revenue | $28.2M | +209.6% |
| Gross Profit | $65.3M | +208.5% |
| R&D Expense | $26.8M | +20.2% |
| SG&A Expense | $69.9M | +82.6% |
| Operating Income | -$31.4M | +20.3% |
| Interest Expense | $3.7M | -3.8% |
| Pre-tax Income | -$36.2M | +18.1% |
| Net Income | -$36.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $201.2M | +686.5% |
| Short-term Investments | $66.9M | +0.0% |
| Accounts Receivable | $27.6M | +365.3% |
| Inventory | $20.6M | +38.7% |
| Current Assets | $252.3M | +112.5% |
| Total Assets | $277.1M | +105.5% |
| Current Liabilities | $23.7M | +1.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.8M | -58.7% |
| Capital Expenditures | $11.9M | +238.4% |
| Investing Cash Flow | $54.5M | +86.3% |
| Financing Cash Flow | $167.9M | — |
| Free Cash Flow | -$57.7M | -78.3% |
| +18.1% |
| EPS (Basic) | -$1.23 | +23.1% |
| EPS (Diluted) | -$1.23 | +23.1% |
| Long-term Debt |
| $58.7M |
| +66.8% |
| Total Liabilities | $89.8M | +33.9% |
| Stockholders' Equity | $187.4M | +176.1% |